ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

CCOP Review Committee Member Objects To “Unwarranted Criticism”

March 4, 1988

In Brief: ACS Estimates 502,000 U.S. Cancer Deaths, 178,000 Avoidable With Early Diagnosis

March 17, 1989

Minority Demonstration Centers Concept

May 12, 1989

In Brief: Moffitt Cancer Center Awarded Core Grant; Biotech Industry Honors Jeffords, Bliley

May 29, 1998

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

Bethesda System Revised For Reporting Pap Test Results

April 26, 2002